ACE2 and COVID-19: The novel coronavirus SARS-CoV-2 binds to human angiotensin-converting enzyme II (ACE2) through its expressed S-protein and enters the cell, while ACE2 activates the expression of CCL2, and studies have also shown that the pathogenesis of COVID-19 is closely related to the excessive release of CCL2 [21–23].